Affect of genetic polymorphisms on pain perception and pain management in lung cancer survivors


  • Shailendra Kapoor, MD



no abstract

Author Biography

Shailendra Kapoor, MD

Private practice, Mechanicsville, Virginia


Simone CB II, Vapiwala N, Hampshire MK, et al.: Palliative care in the management of lung cancer: Analgesic utilization and barriers to optimal pain management. J Opioid Manag. 2012; 8: 9-16.

Rausch SM, Gonzalez BD, Clark MM, et al.: SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors. Lung Cancer. 2012 (in press).

Reyes-Gibby CC, Spitz MR, Yennurajalingam S, et al.: Role of inflammation gene polymorphisms on pain severity in lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2636-2642.

Reyes-Gibby CC, El Osta B, Spitz MR, et al.: The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care. Cancer Epidemiol Biomarkers Prev. 2008; 17: 3262-3267.

Reyes-Gibby CC, Spitz M, Wu X, et al.: Cytokine genes and pain severity in lung cancer: Exploring the influence of TNFalpha-308 G/A IL6-174G/C and IL8-251T/A. Cancer Epidemiol Biomarkers Prev. 2007; 16: 2745-2751.

Daniel M, Keefe FJ, Lyna P, et al.: Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levels. J Pain. 2009; 10: 323-328.




How to Cite

Kapoor, MD, S. “Affect of Genetic Polymorphisms on Pain Perception and Pain Management in Lung Cancer Survivors”. Journal of Opioid Management, vol. 8, no. 3, May 2012, p. 142, doi:10.5055/jom.2012.0108.



Letters to the Editor